Press "Enter" to skip to content

New patent expiration for Teva Pharm drug ARMONAIR RESPICLICK

0

Annual Drug Patent Expirations for ARMONAIR+RESPICLICK
Annual Drug Patent Expirations for ARMONAIR+RESPICLICK

Armonair Respiclick is a drug marketed by Teva Pharm
and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.

This drug has two hundred and ninety-five patent family members in thirty-one countries.

The generic ingredient in ARMONAIR RESPICLICK is fluticasone propionate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Do NOT follow this link or you will be banned from the site!